HEPATITIS delta virus (HDV) is a subviral human pathogen that requires hepatitis B virus (HBV) for packaging(1,2). Concurrent infection by HBV and HDV increases the risk of severe liver disease compared to infection with HBV alone(3). The HDV genome is a closed circular RNA of about 1,700 bases which is replicated through an RNA intermediate, the antigenome(4). Both RNAs cars be folded into highly base-paired, rod-shaped structures, similar to the plant viroid RNAs(5). Two forms of the sole HDV protein, hepatitis delta antigen, are derived from a single open reading frame by RNA editing; the enzymes responsible for the editing have not been characterized, Here we report that the purified enzyme dsRAD (for double-stranded-RNA-adenosine deaminase) can edit HDV antigenomic RNA in vitro. Most important, we observe that mutations in critical sequences of the antigenome have identical effects on in vitro and in vivo editing, suggesting that dsRAD, or a closely related enzyme, is responsible for editing HDV RNA in vivo.